Korea Investment Corp’s NovoCure NVCR Stock Holding History

Korea Investment Corp’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,150	Closed	-$1.38M	–	762
2023 Q2	$1.38M	Buy	33,150 +6,773	+26%	+$421K	﹤0.01%	698
2023 Q1	$1.59M	Sell	26,377 -7,986	-23%	-$638K	﹤0.01%	692
2022 Q4	$2.52M	Sell	34,363 -5,156	-13%	-$388K	0.01%	661
2022 Q3	$3M	Buy	39,519 +13,285	+51%	+$1.04M	0.01%	635
2022 Q2	$1.82M	Buy	26,234 +7,734	+42%	+$583K	0.01%	685
2022 Q1	$1.53M	Sell	18,500 -500	-3%	-$36.8K	﹤0.01%	681
2021 Q4	$1.43M	Buy	19,000 +1,300	+7%	+$130K	﹤0.01%	677
2021 Q3	$2.06M	Sell	17,700 -600	-3%	-$90.7K	0.01%	659
2021 Q2	$4.06M	Sell	18,300 -700	-4%	-$136K	0.01%	574
2021 Q1	$2.51M	Sell	19,000 -9,700	-34%	-$1.53M	0.01%	631
2020 Q4	$4.97M	Buy	+28,700	New	+$3.93M	0.01%	489

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Korea Investment Corp's NVCR Position: Q3 2023 in Review

Korea Investment Corp sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 33,150 shares — an estimated $1.38M sold.

Korea Investment Corp first reported a position in NVCR in Q4 2020 and held it in 11 quarters. The position peaked at $4.97M in Q4 2020. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

Korea Investment Corp reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
Korea Investment Corp sold 33,150 NovoCure shares in Q3 2023, an estimated $1.38M.
Korea Investment Corp first reported a position in NovoCure in Q4 2020 and held it in 11 quarters.
Korea Investment Corp's NovoCure position peaked at $4.97M in Q4 2020.
226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Korea Investment Corp's 13F filing for Q3 2023, filed 13 Nov 2023.